TALazoparib and Avelumab as Maintenance Therapy in Platinum-Sensitive Metastatic or Locally Advanced URothelial Carcinoma
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The main objectif is to determine the efficacy of a maintenance treatment combining
Talazoparib and Avelumab after platinum-based chemotherapy in patients with locally
advanced/metastatic urothelial carcinoma.